$ cat ./records/gates-foundation-grants-29-97-million-to-cor-ntd-for-lymphatic-fi-2018.txt
Gates Foundation Grants $29.97 Million to COR-NTD for Lymphatic Filariasis and Schistosomiasis Operational Research
[RECORD.TXT] · cat --full
The Gates Foundation awarded the Task Force for Global Health $29.97 million over five years to fund the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD). The grant supported more than 180 operational research studies with over 100 international partners in 55 countries, targeting remaining barriers to eliminating lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminths, and trachoma. COR-NTD's evidence directly informs WHO NTD programme strategy and country-level programme adaptations.
Source: https://www.taskforce.org/new-29-9m-funding-boosts-fight-against-neglected-tropical-diseases/
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Breakthrough Energy Ventures Leads $26 Million Series A for Malta Inc. Molten-Salt Thermal Energy Storage
Next →
CEPI Funded Nipah Virus Vaccine Candidate Enters First Human Phase 1 Trial
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.